Connect with us

Published

on

The government has confirmed that two-thirds of NHS England cancer targets will be scrapped by the autumn as it aims to bring cancer care “into the modern era”.

The new guidelines will see the 10 targets currently in place reduced to three – and the two-week wait target will be scrapped in favour of the Faster Diagnosis Standard.

Labour has accused Rishi Sunak of “moving the goalposts and cutting standards for patients” rather than cutting waiting times, which is one of his five pledges.

As it stands, 93% of people referred urgently by their GP with suspected cancer must be seen by a specialist within 14 days – although that target has not been achieved since early 2018.

The new Faster Diagnosis Standard was initially introduced in April 2021, and has been under “rigorous consultation”, according to the government.

Please use Chrome browser for a more accessible video player

Cancer target scrapped in England

The aim is for 75% of patients to be told within 28 days of referral whether or not they have cancer, reducing anxiety for patients and speeding up treatment pathways.

However, since the new standard was introduced 16 months ago, the target has not once been met, according to research from the House of Commons library.

The new targets for NHS England cancer care are as follows:

• The 28-day Faster Diagnosis Standard, under which patients with suspected cancer referred by a GP should be diagnosed within 28 days;

• The 62-day referral to treatment to ensure patients who have been referred and diagnosed should start treatment within that time frame;

• The 31-day decision to treat – this means patients with a cancer diagnosis should have a decision made on their first or subsequent treatment and should start it within 31 days.

Prime Minister Rishi Sunak with Health Secretary Steve Barclay speaking to staff during a visit to Rivergreen Medical Centre in Nottingham
Image:
Prime Minister Rishi Sunak and Health Secretary Steve Barclay speaking to staff during a visit to Rivergreen Medical Centre in Nottingham in June

Professor Sir Stephen Powis, national NHS medical director, said: “The NHS is already catching more cancers at an earlier stage, when they are easier to treat than ever before and the Faster Diagnosis Standard will allow us to build on this excellent progress.

“The updated ambitions will mean the NHS can be even more focused on outcomes for patients, rather than just appointment times, and it’s yet another example of the NHS bringing cancer care into the modern era of care.”

Health minister Will Quince said the “biggest factor in people surviving cancer is the stage at which they are diagnosed”, and added: “We have listened to the advice from clinical experts and NHS England to reform cancer standards which will speed up diagnosis for patients.”

Last week, NHS England data revealed 261,006 urgent cancer referrals were made by GPs in June – up 13% year on year from 231,868 in June 2022.

Read more:
NHS handed £250m to tackle waiting times

Wales health minister hits back at Steve Barclay’s offer to treat patients in England
NHS patients could be prescribed weight loss jabs

However, cancer wait times remain well below the government targets.

From October 2022 to June 2023, 418,000 people waited longer than the two-week period from referral to seeing a specialist, and in the same period, 623,000 people were still waiting for either a diagnosis or cancer to be ruled out 28 days after an urgent referral.

Oncologist Professor Pat Price, co-founder of the #CatchUpWithCancer campaign and chairwoman of charity Radiotherapy UK, welcomed the “simplification” of the system, she said targets should be “much higher”.

“The only measure that will ‘move the dial’ is the development and implementation of a radical new plan backed up with smart investment in people and kit,” she said.

But Genevieve Edwards, chief executive of Bowel Cancer UK, said it is “good news” for bowel cancer services and will “help NHS policymakers and the government to identify parts of the country that may need extra support”.

Labour 'relieved' with NHS plan
Image:
Labour’s Wes Streeting was diagnosed with and treated for kidney cancer in 2021

Labour’s shadow health secretary Wes Streeting – who has himself undergone NHS cancer treatment – blasted the government’s record on cancer care, saying patients are “left waiting dangerously long for diagnosis and treatment” which means that for some, “their treatment won’t start until it’s too late”.

He added: “Since Rishi Sunak became prime minister, hundreds of thousands of patients have been let down. Now he’s moving the goalposts and cutting standards for patients, when he should be cutting waiting times instead.

“Having been through treatment for kidney cancer, I know the importance of early diagnosis and fast treatment. With Labour, the NHS will be there for cancer patients when they need it, once again.”

Continue Reading

Politics

Gensler separates Bitcoin from pack, calls most crypto ‘highly speculative’

Published

on

By

Gensler separates Bitcoin from pack, calls most crypto ‘highly speculative’

Former US Securities and Exchange Commission Chair Gary Gensler renewed his warning to investors about the risks of cryptocurrencies, calling most of the market “highly speculative” in a new Bloomberg interview on Tuesday.

He carved out Bitcoin (BTC) as comparatively closer to a commodity while stressing that most tokens don’t offer “a dividend” or “usual returns.”

Gensler framed the current market backdrop as a reckoning consistent with warnings he made while in office that the global public’s fascination with cryptocurrencies doesn’t equate to fundamentals.

“All the thousands of other tokens, not the stablecoins that are backed by US dollars, but all the thousands of other tokens, you have to ask yourself, what are the fundamentals? What’s underlying it… The investing public just needs to be aware of those risks,” he said.

Gensler’s record and industry backlash

Gensler led the SEC from April 17, 2021, to Jan. 20, 2025, overseeing an aggressive enforcement agenda that included lawsuits against major crypto intermediaries and the view that many tokens are unregistered securities.

Related: House Republicans to probe Gary Gensler’s deleted texts

The industry winced at high‑profile actions against exchanges and staking programs, as well as the posture that most token issuers fell afoul of registration rules.

Gary Gensler labels crypto as “highly speculative.” Source: Bloomberg

Under Gensler’s tenure, Coinbase was sued by the SEC for operating as an unregistered exchange, broker and clearing agency, and for offering an unregistered staking-as-a-service program. Kraken was also forced to shut its US staking program and pay a $30 million penalty.

The politicization of crypto

Pushed on the politicization of crypto, including references to the Trump family’s crypto involvement by the Bloomberg interviewer, the former chair rejected the framing.

“No, I don’t think so,” he said, arguing it’s more about capital markets fairness and “commonsense rules of the road,” than a “Democrat versus Republican thing.”

He added: “When you buy and sell a stock or a bond, you want to get various information,” and “the same treatment as the big investors.” That’s the fairness underpinning US capital markets.

Related: Coinbase files FOIA to see how much the SEC’s ‘war on crypto’ cost

ETFs and the drift to centralization

On ETFs, Gensler said finance “ever since antiquity… goes toward centralization,” so it’s unsurprising that an ecosystem born decentralized has become “more integrated and more centralized.”

He noted that investors can already express themselves in gold and silver through exchange‑traded funds, and that during his tenure, the first US Bitcoin futures ETFs were approved, tying parts of crypto’s plumbing more closely to traditional markets.

Gensler’s latest comments draw a familiar line: Bitcoin sits in a different bucket, while most other tokens remain, in his view, speculative and light on fundamentals.

Even out of office, his framing will echo through courts, compliance desks and allocation committees weighing BTC’s status against persistent regulatory caution of altcoins.

Magazine: Solana vs Ethereum ETFs, Facebook’s influence on Bitwise — Hunter Horsley